• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    American Vanguard Reports First Quarter 2025 Results

    6/6/25 6:15:00 AM ET
    $AVD
    Agricultural Chemicals
    Industrials
    Get the next $AVD alert in real time by email

    Substantially Reduced Operating Expenses

    Materially Decreased Net Working Capital Consumption

    Industry In the Early Innings of a Recovery

    American Vanguard® Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2025.

    Financial and Operational Highlights – First Quarter 2025 versus First Quarter 2024:

    • Net sales of $115.8 million v. $135.1 million;
    • Adjusted EBITDA1 of $3.0 million v. $15.5 million;
    • EPS of $(0.30) v. $0.06

    Other Operational Highlights:

    • Reduced net working capital by $85M year-over-year
    • While operating expenses decreased by 5% on a GAAP basis, as compared to the year ago period, they decreased by 14% excluding transformation expenses and a non-recurring item

    CEO Douglas A. Kaye III stated, "The first quarter of 2025 presented a challenging environment for suppliers to the global agricultural sector, continuing trends that we have experienced over the past 18-24 months. Against a backdrop of global economic uncertainty and generally high interest rates, customers focused on managing working capital by reducing inventory and limiting procurement to a just-in-time basis. In the face of these conditions, our results for the quarter declined, as compared to last year. While I am pleased with the progress we have made, if market conditions do not improve, we will enact further cost reduction initiatives over the coming quarters. We have made meaningful improvement to our cost structure, but much of that progress is currently being overshadowed in our financial results so far this year by the continued weakness in the agricultural environment."

    Mr. Kaye continued, "The environment is beginning to improve in the second quarter, and, like most industry participants in the agricultural chemical industry, we expect the second half of 2025 to be both seasonally stronger and to benefit from improving customer order rates. We expect to realize the benefit of commercial and operational improvements that are either completed or are well underway. As we continue to transform and simplify this business, future margins will improve, and further margin enhancement in 2026 and beyond is the target."

    David T. Johnson, Vice President, CFO and Treasurer, stated "While the industry recovers from its cyclical downturn, the team has made meaningful improvement to the cost structure. We are pleased with the results from our initial efforts to contain costs and will continue to keep a tight rein on non-essential costs for the foreseeable future. In addition to minimizing operating expenses, we have made significant improvements to our balance sheet. We ended the quarter with total debt of $167 million, which was down from $187 million the prior year. Net working capital decreased to $153 million versus $238 million a year ago. We will continue to focus on strengthening our balance sheet and positioning American Vanguard for a return to growth."

    Mr. Kaye concluded, "I believe that simplifying many of the things we do will allow us to better understand what is important and to deliver against high priority tasks. My message across the organization in this regard is straightforward – SIMPLIFY, PRIORITIZE and DELIVER. If we embrace this mantra, I believe that we can reaffirm American Vanguard's position as a trusted provider of proven agricultural and environmental solutions."

    1

    Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently.

    Earnings Conference Call

    The company will be hosting an earnings conference call at 9 am Eastern Time on June 6, 2025. The conference call can be accessed through the following link: https://www.webcaster4.com/Webcast/Page/3070/52413. A replay can also be accessed through the website. In addition, the company plans to post on the Investor Relations section of the company's website a presentation that should be read in connection with this earnings release.

    About American Vanguard

    American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference www.american-vanguard.com.

    The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward-looking statements often use words such as "believe," "expect," "anticipate," "intend," "estimate," "project," "outlook," "forecast," "target," "trend," "plan," "goal," or other words of comparable meaning or future-tense or conditional verbs such as "may," "will," "should," "would," or "could." These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements.

    AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share data)

    (Unaudited)

     

    ASSETS

     

    March 31,

    2025

     

     

    December 31,

    2024

     

    Current assets:

     

     

     

     

     

     

    Cash

     

    $

    11,805

     

     

    $

    12,514

     

    Receivables:

     

     

     

     

     

     

    Trade, net of allowance for credit losses of $10,321 and $9,190, respectively

     

     

    159,559

     

     

     

    169,743

     

    Other

     

     

    8,155

     

     

     

    4,699

     

    Total receivables, net

     

     

    167,714

     

     

     

    174,442

     

    Inventories

     

     

    184,596

     

     

     

    179,292

     

    Prepaid expenses

     

     

    8,507

     

     

     

    7,615

     

    Income taxes receivable

     

     

    5,226

     

     

     

    5,030

     

    Total current assets

     

     

    377,848

     

     

     

    378,893

     

    Property, plant and equipment, net

     

     

    57,016

     

     

     

    58,169

     

    Operating lease right-of-use assets, net

     

     

    18,430

     

     

     

    19,735

     

    Intangible assets, net

     

     

    147,668

     

     

     

    150,497

     

    Goodwill

     

     

    20,291

     

     

     

    19,701

     

    Deferred income tax assets

     

     

    1,331

     

     

     

    1,242

     

    Other assets

     

     

    9,004

     

     

     

    8,484

     

    Total assets

     

    $

    631,588

     

     

    $

    636,721

     

    Liabilities and Stockholders' Equity

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

    Accounts payable

     

    $

    93,920

     

     

    $

    69,159

     

    Customer prepayments

     

     

    24,460

     

     

     

    52,675

     

    Accrued program costs

     

     

    70,319

     

     

     

    69,449

     

    Accrued expenses and other payables

     

     

    17,119

     

     

     

    31,989

     

    Operating lease liabilities, current

     

     

    5,986

     

     

     

    6,136

     

    Income taxes payable

     

     

    1,261

     

     

     

    2,942

     

    Total current liabilities

     

     

    213,065

     

     

     

    232,350

     

    Long-term debt

     

     

    167,498

     

     

     

    147,332

     

    Operating lease liabilities, long-term

     

     

    13,074

     

     

     

    14,339

     

    Deferred income tax liabilities

     

     

    8,924

     

     

     

    7,989

     

    Other liabilities

     

     

    1,673

     

     

     

    1,601

     

    Total liabilities

     

     

    404,234

     

     

     

    403,611

     

    Commitments and contingent liabilities (Note 13)

     

     

     

     

     

     

    Stockholders' equity:

     

     

     

     

     

     

    Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued

     

     

    —

     

     

     

    —

     

    Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,850,030 shares at March 31, 2025 and 34,794,548 shares at December 31, 2024

     

     

    3,485

     

     

     

    3,479

     

    Additional paid-in capital

     

     

    115,554

     

     

     

    114,679

     

    Accumulated other comprehensive loss

     

     

    (16,904

    )

     

     

    (18,729

    )

    Retained earnings

     

     

    196,420

     

     

     

    204,882

     

     

     

     

    298,555

     

     

     

    304,311

     

    Less treasury stock at cost, 5,915,182 shares at March 31, 2025 and December 31, 2024

     

     

    (71,201

    )

     

     

    (71,201

    )

    Total stockholders' equity

     

     

    227,354

     

     

     

    233,110

     

    Total liabilities and stockholders' equity

     

    $

    631,588

     

     

    $

    636,721

     

    AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)

     

     

     

    For the three months

    ended March 31

     

     

     

    2025

     

     

    2024

     

    Net sales

     

    $

    115,800

     

     

    $

    135,143

     

    Cost of sales

     

     

    (85,609

    )

     

     

    (92,725

    )

    Gross profit

     

     

    30,191

     

     

     

    42,418

     

    Operating expenses

     

     

     

     

     

     

    Selling, general and administrative

     

     

    (26,566

    )

     

     

    (29,469

    )

    Research, product development and regulatory

     

     

    (5,682

    )

     

     

    (5,706

    )

    Transformation

     

     

    (2,253

    )

     

     

    (1,152

    )

    Operating (loss) income

     

     

    (4,310

    )

     

     

    6,091

     

    Change in fair value of an equity investment

     

     

    —

     

     

     

    638

     

    Interest expense, net

     

     

    (3,765

    )

     

     

    (3,693

    )

    (Loss) income before provision for income taxes

     

     

    (8,075

    )

     

     

    3,036

     

    Income tax expense

     

     

    (387

    )

     

     

    (1,484

    )

    Net (loss) income

     

    $

    (8,462

    )

     

    $

    1,552

     

    Net (loss) income per common share—basic

     

    $

    (0.30

    )

     

    $

    0.06

     

    Net (loss) income per common share—assuming dilution

     

    $

    (0.30

    )

     

    $

    0.06

     

    Weighted average shares outstanding—basic

     

     

    28,271

     

     

     

    27,844

     

    Weighted average shares outstanding—assuming dilution

     

     

    28,271

     

     

     

    28,128

     

    AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

    ANALYSIS OF SALES

    (In thousands), (Unaudited)

     

     

     

    For the three months ended

    March 31,

     

     

     

     

     

     

     

     

     

    2025

     

     

    2024

     

     

    Change

     

     

    % Change

     

    Net sales:

     

     

     

     

     

     

     

     

     

     

     

     

    U.S. crop

     

    $

    57,176

     

     

    $

    67,257

     

     

    $

    (10,081

    )

     

     

    -15

    %

    U.S. non-crop

     

     

    15,601

     

     

     

    17,768

     

     

     

    (2,167

    )

     

     

    -12

    %

    Total U.S.

     

     

    72,777

     

     

     

    85,025

     

     

     

    (12,248

    )

     

     

    -14

    %

    International

     

     

    43,023

     

     

     

    50,118

     

     

     

    (7,095

    )

     

     

    -14

    %

    Total net sales

     

    $

    115,800

     

     

    $

    135,143

     

     

    $

    (19,343

    )

     

     

    -14

    %

    Total cost of sales

     

    $

    (85,609

    )

     

    $

    (92,725

    )

     

    $

    7,116

     

     

     

    -8

    %

    Total gross profit

     

    $

    30,191

     

     

    $

    42,418

     

     

    $

    (12,227

    )

     

     

    -29

    %

    Total gross margin

     

     

    26

    %

     

     

    31

    %

     

     

     

     

     

     

    AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

     

    For the three months

    ended March 31

     

     

     

    2025

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

     

     

     

    Net (loss) income

     

    $

    (8,462

    )

     

    $

    1,552

     

    Adjustments to reconcile net (loss) income to net cash used in operating activities:

     

     

     

     

     

     

    Depreciation and amortization of property, plant and equipment and intangible assets

     

     

    4,744

     

     

     

    5,441

     

    Amortization of other long-term assets

     

     

    5

     

     

     

    189

     

    Provision for bad debts

     

     

    1,056

     

     

     

    700

     

    Stock-based compensation

     

     

    559

     

     

     

    2,005

     

    Change in deferred income taxes

     

     

    1,348

     

     

     

    (1,025

    )

    Change in liabilities for uncertain tax positions or unrecognized tax benefits

     

     

    90

     

     

     

    35

     

    Change in equity investment fair value

     

     

    —

     

     

     

    (638

    )

    Other

     

     

    126

     

     

     

    (5

    )

    Foreign currency transaction gains

     

     

    (99

    )

     

     

    (373

    )

    Changes in assets and liabilities associated with operations:

     

     

     

     

     

     

    Decrease (increase) in net receivables

     

     

    6,892

     

     

     

    (5,579

    )

    Increase in inventories

     

     

    (4,721

    )

     

     

    (9,353

    )

    Increase in prepaid expenses and other assets

     

     

    (856

    )

     

     

    (1,466

    )

    Change in income tax receivable and payable, net

     

     

    (1,885

    )

     

     

    1,014

     

    Increase in accounts payable

     

     

    22,966

     

     

     

    2,366

     

    Decrease in customer prepayments

     

     

    (28,215

    )

     

     

    (37,037

    )

    Increase in accrued program costs

     

     

    837

     

     

     

    6,399

     

    Decrease in other payables and accrued expenses

     

     

    (14,961

    )

     

     

    (332

    )

    Net cash used in operating activities

     

     

    (20,576

    )

     

     

    (36,107

    )

    Cash flows from investing activities:

     

     

     

     

     

     

    Capital expenditures

     

     

    (431

    )

     

     

    (3,565

    )

    Proceeds from disposal of property, plant and equipment

     

     

    12

     

     

     

    23

     

    Intangible assets

     

     

    (27

    )

     

     

    (25

    )

    Net cash used in investing activities

     

     

    (446

    )

     

     

    (3,567

    )

    Cash flows from financing activities:

     

     

     

     

     

     

    Payments under line of credit agreement

     

     

    (89,098

    )

     

     

    (35,346

    )

    Borrowings under line of credit agreement

     

     

    109,265

     

     

     

    77,146

     

    Payment of deferred loan fees

     

     

    (687

    )

     

     

    —

     

    Net receipt from the issuance of common stock under ESPP

     

     

    332

     

     

     

    430

     

    Net payment from common stock purchased for tax withholding

     

     

    (11

    )

     

     

    (14

    )

    Payment of cash dividends

     

     

    —

     

     

     

    (834

    )

    Net cash provided by financing activities

     

     

    19,801

     

     

     

    41,382

     

    Net (decrease) increase in cash

     

     

    (1,221

    )

     

     

    1,708

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    512

     

     

     

    585

     

    Cash at beginning of period

     

     

    12,514

     

     

     

    11,416

     

    Cash at end of period

     

    $

    11,805

     

     

    $

    13,709

     

    AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

    RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA

    (Unaudited)

     

    Reconciliation of Net Income to EBITDA

     

    March 31, 2025

     

     

    March 31, 2024

     

    Net income, as reported

     

    $

    (8,462

    )

     

    $

    1,552

     

    Provision for income taxes

     

     

    387

     

     

     

    1,484

     

    Interest expense, net

     

     

    3,765

     

     

     

    3,693

     

    Depreciation and amortization

     

     

    4,749

     

     

     

    5,630

     

    Stock compensation

     

     

    559

     

     

     

    2,005

     

    Dacthal returns

     

     

    (216

    )

     

     

    —

     

    Transformation costs

     

     

    2,191

     

     

     

    1,152

     

    Adjusted EBITDA2

     

    $

    2,973

     

     

    $

    15,516

     

    2

    Adjusted earnings before interest, taxes, depreciation, and amortization. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the above reconciliation. Other companies (including the Company's competitors) may define adjusted EBITDA differently.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250606463941/en/

    Company Contact

    American Vanguard Corporation

    Anthony Young, Director of Investor Relations

    [email protected]

    (949) 221-6119



    Investor Representative

    Alpha IR Group

    Robert Winters

    [email protected]

    (929) 266-6315

     

    Get the next $AVD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVD

    DatePrice TargetRatingAnalyst
    7/22/2024$14.00Buy
    Lake Street
    More analyst ratings